Multiple gut lumen toxins

Multiple gut lumen toxins refer to a diverse array of harmful substances produced within or introduced into the gastrointestinal tract, including bacterial enterotoxins, endotoxins (LPS), and metabolic byproducts like uremic toxins. These molecules play a critical role in the pathogenesis of various conditions, such as Clostridioides difficile-associated diarrhea, where toxins TcdA and TcdB damage the intestinal epithelium, and chronic kidney disease, where the accumulation of gut-derived uremic toxins like indoxyl sulfate promotes systemic inflammation and renal progression [1][2]. Therapeutic strategies targeting these toxins typically involve oral adsorbents, such as AST-120 or activated charcoal, which sequester the toxins within the gut lumen to prevent their absorption or local action [3]. Additionally, monoclonal antibodies like bezlotoxumab can specifically neutralize certain bacterial toxins to prevent disease recurrence [4]. Because this target is a heterogeneous group of molecules rather than a single receptor or enzyme, pharmacological intervention often focuses on broad-spectrum physical adsorption or highly specific ligand-binding to mitigate systemic toxicity and local tissue damage. Citations: [1] Di Bella, S., et al. (2016). J Med Microbiol. [2] Evenepoel, P., et al. (2017). Nephrol Dial Transplant. [3] Schulman, G., et al. (2015). Am J Nephrol. [4] Wilcox, M. H., et al. (2017). N Engl J Med.

Other names

Intestinal toxinsEnterotoxinsGut-derived uremic toxinsBacterial endotoxinsMicrobial metabolitesGastrointestinal toxins

Drugs targeting these toxins primarily function through physical adsorption, ion exchange, or direct immunological neutralization to prevent toxin absorption or local tissue damage.